Michael Gould to Sensitivity and Specificity
This is a "connection" page, showing publications Michael Gould has written about Sensitivity and Specificity.
Connection Strength
0.848
-
CURB-65 Performance Among Admitted and Discharged Emergency Department Patients With Community-acquired Pneumonia. Acad Emerg Med. 2016 Apr; 23(4):400-5.
Score: 0.129
-
An Age-Adjusted D-dimer Threshold for Emergency Department Patients With Suspected Pulmonary Embolus: Accuracy and Clinical Implications. Ann Emerg Med. 2016 Feb; 67(2):249-57.
Score: 0.124
-
Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion? Chest. 2008 Apr; 133(4):1053-4; author reply 1054.
Score: 0.074
-
Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005 Nov; 60(11):949-55.
Score: 0.061
-
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003 Dec 02; 139(11):879-92.
Score: 0.055
-
Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Med Decis Making. 2003 Sep-Oct; 23(5):435-40.
Score: 0.054
-
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med. 2003 May 06; 138(9):724-35.
Score: 0.053
-
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001 Feb 21; 285(7):914-24.
Score: 0.045
-
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 1999 May 18; 130(10):789-99.
Score: 0.040
-
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1999 May 18; 130(10):800-9.
Score: 0.040
-
Identification of benign pulmonary nodules by needle biopsy. Chest. 1998 Jan; 113(1):3-5.
Score: 0.036
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.026
-
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010 May; 137(5):1150-6.
Score: 0.021
-
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008 Feb; 49(2):179-85.
Score: 0.018
-
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):94S-107S.
Score: 0.018
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.018
-
Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med. 2006 Jun 06; 144(11):832-41.
Score: 0.016
-
Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med. 1999 Jul; 5(4):201-7.
Score: 0.010
-
The usefulness of a prenatal genetic questionnaire in genetic risk assessment. Obstet Gynecol. 1996 Nov; 88(5):806-10.
Score: 0.008